Literature DB >> 2040689

Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.

A Chu1, D E Chambers, C C Lin, W D Kuehl, R M Palmer, S Moncada, F R Cobb.   

Abstract

The role of nitric oxide in basal vasomotor tone and stimulated endothelium-dependent dilations in the coronary arteries in chronically instrumented awake dogs was studied by examining the consequences of inhibiting endogenous nitric oxide formation with the specific inhibitor of nitric oxide formation, NG-monomethyl-L-arginine (L-NMMA). In four awake dogs, coronary dimension crystals were chronically implanted on the circumflex artery for the measurement of epicardial coronary diameter, and Doppler flow probes were implanted for quantitation of phasic coronary blood flow (vasomotion of distal regulatory resistance vessels). Basal epicardial coronary diameter, acetylcholine-stimulated endothelium-dependent dilation, and flow-induced endothelium-dependent dilation of the epicardial arteries and phasic blood flow were recorded before, and after 5, 15, 50, and 120 mg/kg of L-NMMA. L-NMMA induced a dose-related increase in basal epicardial coronary vasomotor tone. There was an accompanying increase in aortic pressure and a decrease in heart rate. At doses greater than or equal to 50 mg/kg, rest phasic coronary blood flow was also decreased. Left ventricular end-diastolic pressure and contractility were not significantly changed. In contrast, the flow-induced or acetylcholine-stimulated endothelium-dependent responses were attenuated only after infusion of the highest does of L-NMMA (120 mg/kg). The changes in the basal vasomotor tone and acetylcholine-stimulated endothelium-dependent responses returned towards the control states in the presence of L-arginine (660 mg/kg). These data support the view that nitric oxide plays a significant role in modulating basal vasomotion and endothelial-dependent dilation stimulated by acetylcholine or increase in blood flow in epicardial coronary arteries and also influence the regulation of coronary blood flow during physiologic conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040689      PMCID: PMC296949          DOI: 10.1172/JCI115223

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

Review 1.  Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.

Authors:  L J Ignarro
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

2.  Release of NO and EDRF from cultured bovine aortic endothelial cells.

Authors:  P R Myers; R Guerra; D G Harrison
Journal:  Am J Physiol       Date:  1989-04

3.  NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

Authors:  K Aisaka; S S Gross; O W Griffith; R Levi
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

4.  Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle.

Authors:  K Shikano; E H Ohlstein; B A Berkowitz
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

Review 5.  Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.

Authors:  S Moncada; M W Radomski; R M Palmer
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

Review 6.  Endothelium-derived relaxing and contracting factors.

Authors:  R F Furchgott; P M Vanhoutte
Journal:  FASEB J       Date:  1989-07       Impact factor: 5.191

7.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

8.  A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.

Authors:  D D Rees; R M Palmer; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

9.  Release of different relaxing factors by cultured porcine endothelial cells.

Authors:  C Boulanger; H Hendrickson; R R Lorenz; P M Vanhoutte
Journal:  Circ Res       Date:  1989-06       Impact factor: 17.367

10.  Role of endothelium-derived nitric oxide in the regulation of blood pressure.

Authors:  D D Rees; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more
  34 in total

1.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

Review 2.  Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective.

Authors:  Kejing Chen; Roland N Pittman; Aleksander S Popel
Journal:  Antioxid Redox Signal       Date:  2008-07       Impact factor: 8.401

Review 3.  Coronary endothelial function in health and disease.

Authors:  J C Burnett
Journal:  Drugs       Date:  1997       Impact factor: 9.546

4.  Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli.

Authors:  P Leeson; S Thorne; A Donald; M Mullen; P Clarkson; J Deanfield
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 5.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

6.  Effects of inhibition of nitric oxide formation on the regulation of coronary blood flow in anesthetized dogs.

Authors:  U Solzbach; J Liao; N L Eigler; A M Zeiher
Journal:  Basic Res Cardiol       Date:  1995 Nov-Dec       Impact factor: 17.165

7.  Mediators of coronary reactive hyperaemia in isolated mouse heart.

Authors:  Amanda J Zatta; John P Headrick
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

8.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Authors:  A A Quyyumi; N Dakak; N P Andrews; S Husain; S Arora; D M Gilligan; J A Panza; R O Cannon
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.

Authors:  William J Perkins; Susan Kost; Mark Danielson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

10.  Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production.

Authors:  Jian Sun; Lawrence J Druhan; Jay L Zweier
Journal:  Arch Biochem Biophys       Date:  2009-11-20       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.